PF-07940367
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-07940367, covering 2024-06-13 to 2024-06-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood in Healthy Adults [Phase 1]